Washington [US], June 26 (ANI): Jesse Bloom, a virologist and professor at the Fred Hutchinson Cancer Research Center in Seattle, discovered the deletion of some early sequences of coronavirus from Wuhan which were missing from the Sequence Read Archive, a public archive of high through
Washington [US], June 15 (ANI): Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, suggested a new study led by cancer researchers at UT Southwestern Medical Center.
New Delhi [India], June 4 (ANI): India's first indigenous tumour antigen, SPAG9 discovered by Dr Anil Suri, head of Cancer Research Program at Delhi based National Institute of Immunology (NII), an Autonomous Institute of Department of Biotechnology (DBT), in 1998 has received the trademark
Canberra [Australia], May 16 (ANI): Through the study published in the international journal, Clinical Cancer Research, scientists at Children's Cancer Institute have detailed a new combination of therapies that appears to be highly effective against high-risk neuroblastoma and other forms o
Washington [US], March 16 (ANI): Engineers at the Massachusetts Institute of Technology have characterized the properties of the protective membrane around tumours and found that this lining may be a good target for therapies to prevent metastasis.
Stockholm [Sweden], March 5 (ANI): Keeping an eye on the recent therapeutic antibodies discoveries that have transformed the treatment of cancer, researchers at Lund University in Sweden have developed a new, efficient method based on genetic scissors CRISPR-Cas9, that facilitates antibody d
Washington [US], February 21 (ANI): A team of scientists from Australia published a study in the journal Clinical Cancer Research that shows their new discovery of a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.
Washington [US], February 15 (ANI): Recent research in a SWOG Cancer Research Network trial that put three targeted drugs to the test, found cabozantinib, which is a small molecule inhibitor, most effective in treating patients with metastatic papillary kidney cancer.
Washington [US], February 14 (ANI): In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practic
Washington [US], February 13 (ANI): A solitary strain of Bacteroides fragilis altogether diminished graft-versus-host disease (GVHD) by ensuring gut integrity, suggested the findings of a new study led by cancer researchers of Medical University of South Carolina (MUSC).
Washington [US], February 11 (ANI): A new study led by cancer researchers of Medical University of South Carolina (MUSC) found that a solitary strain of Bacteroides fragilis altogether diminished graft-versus-host disease (GVHD) by ensuring gut integrity.
Washington [US], November 12 (ANI): Scientists at Sanford Burnham Prebys Medical Discovery Institute, University of California San Diego School of Medicine and Hopp Children's Cancer Center Heidelberg (KiTZ) have demonstrated that personalised drug screens can be used to identify new therape